Dianthus Therapeutics's market cap is currently $701.45M. The company's EPS TTM is $-2.498; its P/E ratio is ―; Dianthus Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.83M	$ 6.42M	$ 1.48M	$ 0.00	$ 0.00
Gross Profit	$ 2.47M	$ 6.27M	$ -544.00K	$ -1.98M	$ -1.84M
Operating Income	$ -48.17M	$ -29.70M	$ -13.09M	$ -78.70M	$ -82.97M
EBITDA	$ -48.17M	$ -29.56M	$ -13.09M	$ -72.96M	$ -74.93M
Net Income	$ -43.55M	$ -28.48M	$ -13.11M	$ -74.94M	$ -76.77M
Balance Sheet
Cash & Short-Term Investments	$ 173.72M	$ 75.49M	$ 7.64M	$ 148.84M	$ 145.73M
Total Assets	$ 179.41M	$ 83.11M	$ 9.45M	$ 161.62M	$ 161.51M
Total Debt	$ 585.00K	$ 788.00K	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -131.74M	$ -14.58M	$ -7.64M	$ -58.15M	$ -65.07M
Total Liabilities	$ 10.54M	$ 127.48M	$ 26.70M	$ 17.71M	$ 20.32M
Stockholders' Equity	$ 168.87M	$ -44.37M	$ -17.25M	$ 143.91M	$ 141.19M
Cash Flow
Free Cash Flow	$ -36.97M	$ -29.21M	$ -9.94M	$ -64.42M	$ -60.16M
Operating Cash Flow	$ -36.86M	$ -29.07M	$ -9.90M	$ -64.02M	$ -57.10M
Investing Cash Flow	$ 20.25M	$ -59.82M	$ -33.00K	$ -10.63M	$ 1.53M
Financing Cash Flow	$ 133.57M	$ 96.68M	$ 14.91M	$ 67.74M	$ 62.30M

Currency in USD

Dianthus Therapeutics Earnings and Revenue History

Income Statement >

Dianthus Therapeutics Debt to Assets

Balance Sheet >

Dianthus Therapeutics Cash Flow

Cash Flow >

Dianthus Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing